Overview

A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance

Status:
Completed

Trial end date:
2014-10-01

Target enrollment:

Participant gender:

Summary

This study is being conducted to evaluate the safety, tolerability and early efficacy of IV TD 8954 compared to metoclopramide in critically ill subjects, aged 18 to 85 years, who are admitted to the intensive care require mechanical ventilation, and are intolerant to enteral feeding.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Takeda
Theravance Biopharma R & D, Inc.

Collaborator:

Theravance Biopharma

Treatments:

Metoclopramide